Current Oncology, Free Full-Text

Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment options for metastatic TNBC, including recent advances with the use of immunotherapy, PARP inhibitors and antibody-drug conjugates. This review also explores new agents and novel combinations arising in the field for the treatment of advanced TNBC.

Living with Cancer Resources and Support – February 2022

Reach Oncologists with Elsevier (EMEALAAP version)

Current Oncology, Free Full-Text

Every year, the Naddeo/Aparicio - United Hospice, Inc.

Current Oncology 2023 - Browse Issues

Current Oncology An Open Access Journal from MDPI

Cancer - Wiley Online Library

Home - American Society for Radiation Oncology (ASTRO)

ECU Health to offer free screenings for prostate cancer in

What is secondary lung cancer?

Current Oncology, Free Full-Text

7th Singapore Society of Oncology Annual Scientific Meeting 2022 – Malaysian Oncological Society

PDF) Publisher's Note: Continued Publication of Current Oncology